Evidence of Chronic Complement Activation in Asymptomatic Pediatric Brain Injury Patients: A Pilot Study
Authors:
- Scott A. HolmesSHScott A. Holmes
- Joud Mar’iJMJoud Mar’i
- Jordan LemmeJLJordan Lemme
- Anne Margarette MaalloAMAnne Margarette Maallo
- Alyssa LebelALAlyssa Lebel
- Laura SimonsLaura Simons
- Michael J. O’brienMOMichael J. O’brien
- David ZurakowskiDZDavid Zurakowski
- Rami BurnsteinRBRami Burnstein
- David BorsookDBDavid Borsook
Open Access
Abstract
Physical insult from a mild Traumatic Brain Injury (mTBI) leads to changes in blood flow in the brain and measurable changes in white matter, suggesting a physiological basis for chronic symptom presentation. Post-traumatic headache (PTH) is frequently reported by persons after an mTBI that may persist beyond the acute period (>3 months). It remains unclear whether ongoing inflammation may contribute to the clinical trajectory of PTH. We recruited a cohort of pediatric subjects with PTH who had an acute or a persistent clinical trajectory, each around the 3-month post-injury time point, as well as a group of age and sex-matched healthy controls. We collected salivary markers of mRNA expression as well as brain imaging and psychological testing. The persistent PTH group showed the highest levels of psychological burden and pain symptom reporting. Our data suggest that the acute and persistent PTH cohort had elevated levels of complement factors relative to healthy controls. The greatest change in mRNA expression was found in the acute-PTH cohort wherein the complement cascade and markers of vascular health showed a prominent role for C1Q in PTH pathophysiology. These findings (1) underscore a prolonged engagement of what is normally a healthy response and (2) show that a persistent PTH symptom trajectory may parallel a poorly regulated inflammatory response.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (5R01NS095655-05)
This publication has 71 references indexed in Scilit:
- Collaboration gets the most out of softwareeLife, 2013
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine productionJournal of Neurochemistry, 2010
- C1q Differentially Modulates Phagocytosis and Cytokine Responses during Ingestion of Apoptotic Cells by Human Monocytes, Macrophages, and Dendritic CellsThe Journal of Immunology, 2009
- C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice*Critical Care Medicine, 2009
- Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in miceJournal of Neuroinflammation, 2007
- Synaptic Pathology, Altered Gene Expression, and Degeneration in Photoreceptors Impacted by DrusenInvestigative Ophthalmology & Visual Science, 2005
- Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injuryJournal of Neuroimmunology, 1997
- The Rivermead head injury follow up questionnaire: a study of a new rating scale and other measures to evaluate outcome after head injury.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- The Pain Catastrophizing Scale: Development and validation.Psychological Assessment, 1995